Literature DB >> 31618554

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

Onofre Moran-Mendoza1, Bader Alharthi1, Marie Clements-Baker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31618554     DOI： 10.1056/NEJMc1910735

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).

Authors:  Paolo Spagnolo; Oliver Distler; Christopher J Ryerson; Argyris Tzouvelekis; Joyce S Lee; Francesco Bonella; Demosthenes Bouros; Anna-Maria Hoffmann-Vold; Bruno Crestani; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2020-10-09       Impact factor: 19.103

2.  Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis.

Authors:  Yehui Li; Wen Zhu; Hailang He; Yordan Angelov Garov; Le Bai; Li Zhang; Jing Wang; Jinghai Wang; Xianmei Zhou
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.